An article to understand the history of the 11th edition of Chinese Pharmacopoeia

In June 2020, the Pharmacopoeia of the people's Republic of China (hereinafter referred to as "the Chinese Pharmacopoeia"), which was compiled by the State Pharmacopoeia Committee, was officially launched in 2020, and the new pharmacopoeia will be received by the pharmaceutical people all over the country in successionThe Chinese pharmacopoeia is the legal technical standard to be followed by relevant units such as drug development, production, operation, use and supervision< br / > < br / > < br / > in 1953, the first Pharmacopoeia of the people's Republic of China was born since the founding of the people's Republic of ChinaIt has been published three times since 1963, 1977 and 1985Since 1985, it has been published regularly every five yearsBy 2020, it has published 11 editions in totalThere are 319 new varieties, 3177 revised varieties, no more 10 varieties, 4 varieties adjusted and merged, and 5911 varieties in total< br / > there are 2711 kinds of one traditional Chinese Medicine collected, including 117 new ones and 452 revised ones; < br / > there are 2712 kinds of two chemical drugs collected, including 117 new ones and 2387 revised ones; < br / > there are 153 kinds of three biological products collected, including 20 new ones and 126 revised ones; there are 2 general principles and 4 general theories of biological products added; < br / > there are 361 general technical requirements collected in four parts, Among them, there are 38 general principles of preparations (revised 35), 281 test methods and other general principles (newly increased 35, revised 51), 42 guiding principles (newly increased 12, revised 12); 335 kinds of pharmaceutical excipients are collected, 65 of which are newly increased, 212 of which are revised< br / > since the founding of the people's Republic of China, the development history of 11 versions and the number of varieties collected are shown in the following figure: < br / > < br / > < br / > < br / > < br / > according to the constitution of the Pharmacopoeia Committee and the working procedures of the Chinese Pharmacopoeia, the 2020 version of the Pharmacopoeia of the people's Republic of China has been issued in June 2020, officially implemented on December 1, 2020, according to the requirements of the implementation practice of the calendar version of the Pharmacopoeia, The drugs produced or imported from December 1, 2020 shall comply with the relevant provisions of Pharmacopoeia 2020Since the founding of the people's Republic of China, a total of 11 versions have been issued and implemented, as shown in the figure below: < br / > < br / > < br / > < br / / / > since the first Pharmacopoeia Committee was established in 1950, the party and the government have attached great importance to the work of drug standardsThe chairman of the Pharmacopoeia Committee is basically the principal of the health administration department of the State Council or the drug regulatory department of the State Council< br / > < br / > references < br / > [1]